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AbstrAct
The association between obesity and several diseases is well known, but an association with asthma has 
been much less described. Epidemiological studies have shown that obesity is an independent risk factor 
for asthma in children and adults. Fundamental is the influence of the definition of the type of asthma on 
the link between those two diseases. Several reports have shown a stronger association between obesity 
and clinical asthma phenotypes than with physiological and inflammatory asthma phenotypes. Among 
the mechanisms that have been proposed to explain the obesity-asthma relationship, the immunological, 
hormonal and environmental are the most important; however, the impact of genetic factors should also 
be considered. Environmental factors such as high-calorie and low antioxidant diet, low maternal vitamin 
consumption and in particular low vitamin D have been recently discussed. Serum concentration of 25(OH)D 
has been found to be insufficient in children with asthma. Low 25-hydroxyvitamin D concentration leads 
to increasing asthma severity and requires more intensive glucocorticoids treatment. 25(OH)D may have 
a protective effect against asthma exacerbations as it enhances steroid responsiveness. The nature of 
the asthma-obesity relationship is very complex and involves several mechanisms. Among these, bron-
chial smooth muscle cells dysfunction, inflammatory mediators and oxidative stress, dietary and genetic 
factors play major roles.
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Introduction
An association between obesity and several diseas-
es other than pulmonary diseases, is well known [1]. 
In spite of the fact that the prevalence of both obesity 
and asthma is increasing concomitantly, an association 
between them has been much less described and the 
causes underlying obesity’s impact on asthma risk re-
main a topic for further investigation. Epidemiological 
studies have shown that obesity is an independent risk 
factor for asthma in children and adults [2, 3]. Obese 
children are at increased risk for developing asthma, one 
of the commonest chronic diseases among this popula-
tion. Studies reporting the link between asthma risk and 
overweight / obesity in children and adolescents have 
produced inconsistent findings. However, it appears 
that increasing body mass in children and adolescents 
is not only associated with an increasing prevalence 
of asthma varying according to race and ethnicity, but 
also appears to further exacerbate asthma and requires 
escalating pharmacological intervention [4]. 
Another issue which should be addressed is the 
influence of asthma definition on the link between 
obesity and asthma. It is important to rule out the asso-
ciation dependent on the respiratory symptoms which 
are caused by obesity. One of the best approaches 
to define asthma is the measurement of bronchial hy-
perresponsiveness using a test with methacholine [5]. 
Cetlin et al. reported no positive association between 
obesity and asthma defined by symptoms associated 
with a positive methacholine challenge test. On the 
contrary, they found an association when the diagnosis 
of asthma was previously made by a physician [3]. In 
children, physician-diagnosed asthma has been found 
to be associated with higher body mass index percen-
tile, body fat and waist circumference [6]. 
Obese asthmatics
Several reports have supported a stronger associa-
tion of obesity with self-reported wheeze, use of asthma 
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medications and other clinically defined asthma pheno-
types than with physiological (e.g. airway hyperreactivity 
or bronchodilator responsiveness of forced expiratory 
volume in 1 s (FEV1) and inflammatory phenotypes of 
asthma (such as sputum cell counts and differentials, 
exhaled nitric oxide) [7–12]. 
 On the other hand, the effect of obesity is not equal 
in all asthmatics. In adults, obesity is a characteristic fea-
ture of females with late-onset asthma having a higher 
degree of airway eosinophilic inflammation, moderately 
increased IgE concentrations but less atopy [13]. In 
early-onset asthma, more allergic symptoms, atopy, 
higher IgE concentrations and a lower degree of eosino 
philic inflammation are typical features. Very recent 
data suggests that the severity and characteristics of 
asthma depend on the age of asthma onset. In late-on-
set asthma, obesity and increased asthma severity are 
more likely to be causatively associated, whereas in 
early-onset asthma, more severe asthma symptoms 
are the effect of significant body weight increase in 
asthmatics [13]. Asthma has been found to be related 
to excess body fat, at least in women. However, due to 
inaccurate measurement of fat deposits in the visceral 
area by DEXA, it appears that the excess of lean mass 
better predicts asthma among obese women [1]. 
biological mechanisms relating asthma 
to obesity
Several mechanisms have been proposed that 
relate asthma to obesity, among them immunological, 
hormonal and environmental. The immunological 
mechanism involving Th2 cells and proinflammatory 
state may link obesity to asthma. Activated CD4+ T hel- 
per cells 2 (Th2) release interleukins IL-4, IL-5, IL-13 
and regulate immune response by stimulating IgE pro-
duction. Following allergen inhalation, IgE binds to mast 
cells and basophils, causing degranulation and the re-
lease of preformed and de novo synthesised mediators 
such as leukotrienes, prostaglandins and several proin-
flammatory cytokines (TNF-a, IL-1, IL-6) causing bron-
chial spasms and increased mucus production [14]. 
Enhanced leukotriene synthesis may contribute to the 
obese asthma phenotype.
Elevated TNF-a in asthma is linked to the production 
of IL-4 and IL-6 in bronchial epithelium. Serum TNF-a is 
also increased in obesity. This is especially interesting 
because this cytokine increases calcium signalling to 
a variety of contractile agonists in airway smooth mus-
cle cells through TNF receptors expressed on these 
cells [15]. Single nucleotide polymorphisms in the 
TNF-a gene have been associated with both asthma and 
obesity [16]. Plasminogen activator inhibitor (PAI-1), 
that is elevated in obesity, may promote the devel-
opment of asthma by regulating airway remodelling, 
airway hyper-responsiveness (AHR) and allergic in-
flammation [17]. 
IL-5 is involved in the late phase of allergic reaction, 
and promotes differentiation of eosinophils and their 
release. It has been shown that human Th2 cells differ-
entiated in vitro are involved in the selective expression 
of the gene for pro-melanin-concentrating hormone 
(PMCH), a precursor of orexigenic peptide, melanin 
concentrating hormone (MCH). PMCH plays an import-
ant role, acting in the hypothalamus, to stimulate the 
appetite in rodents and a receptor for MCH (MCHR1) 
has been identified [18]. In humans, two MCH recep-
tors are present (MCHR1 and MCHR2) and activated 
Th2 cells have been shown to release MCH-containing 
proteins [19]. The proteins derived from PMCH secreted 
to the circulation following Th2 activation in asthma may 
increase appetite by stimulating the hypothalamus, 
which may relate asthma to obesity through a link of 
allergic inflammation to energy homeostasis. 
Another mechanism linking obesity to asthma is the 
role of mediators of energy metabolism, adipocytokines 
such as leptin and adiponectin and hormone ghrelin [20]. 
Leptin, a pro-inflammatory adipocytokine, is expressed 
not only in adipocytes but also in the lungs [21]. This 
adipocytokine enhances Th1 cells proliferation, and 
downregulates the function of other cells associated 
with asthma, but it also may affect subepithelial neo-
vascularisation and vascular permeability through the 
action of vascular endothelial growth factor (VEGF) 
released by airway smooth muscle cells [22, 23]. 
Adiponectin, an anti-inflammatory adipokine and its 
four receptors, besides adipocytes, is expressed in 
multiple cell types in the lung [24]. A decrease of 
serum adiponectin in obesity suppresses secretion of 
anti-inflammatory IL-10, whereas a decrease of serum 
ghrelin causes enhanced release of pro-inflammatory 
cytokines (IL-1b, IL-6 and TNF-a). Altogether, this leads 
to the susceptibility of hyperactive immune system to 
the development of allergic diseases. Recent data from 
children with asthma has shown that obesity worsens 
the symptoms of asthma, and that moreover leptin, 
adiponectin and ghrelin are involved in the inflamma-
tory state observed in this disease, especially among 
obese children [20]. It seems that the contribution of 
adipokines to the asthma-obesity relationship is small 
and may depend on their airway concentration [1]. 
Factors relating obesity to asthma 
Among factors relating obesity to asthma, dietary 
factors, lack of physical exercise, foetal programming 
and genetics have been recently discussed [16]. 
Environmental factors such as high-calorie and low 
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antioxidant diet, and low maternal vitamin consump-
tion, especially low vitamin D, may lead to both obesity 
and asthma. Asthma may be induced by an increase 
of proinflammatory mediators and oxidative stress, 
through toll-like receptors present on airway inflamma-
tory cells and the NF-kB pathway, as a consequence 
of the excess saturated fats in the diet [16]. In obese 
adult asthmatics, excess oxidative stress is reflected by 
increased levels of 8-isoprostane and other biomark-
ers. These biomarkers are elevated both in the blood 
and the lungs of obese patients with asthma. Enhanced 
oxidative stress may worsen the responsiveness to 
corticosteroid therapy [16]. 
 Moreover, the so-called Western diet contains more 
omega-6 than omega-3 polyunsaturated fatty acids that 
enhances proinflammatory effect on the airways and de-
creases lung function. Serum concentration of 25(OH)D 
reflecting vitamin D status has been found to be insuf-
ficient in children with asthma. Lower 25-hydroxyvi-
tamin D concentration leads to increasing asthma 
severity and requires more intensive treatment with 
glucocorticoids. As 25(OH)D may enhance induction 
of anti-inflammatory IL-10 by glucocorticoids, hypovi-
taminosis D causes the need for higher corticosteroid 
use [25].
25-hydroxyvitamin D and asthma
25-hydroxyvitamin D has been shown to exert sig-
nificant immunomodulatory effects [26]. Hydroxylation 
of 25(OH)D, catalysed by CYP27B1, to give the active 
form 1a,25(OH)2D has been found not only in the kid-
neys but also in several other extrarenal cells such as 
macrophages and dendritic cells. Additionally, vitamin D 
receptor (VDR) has been identified on B and T lympho-
cytes. It has been reported that 25(OH)D insufficiency 
may contribute to the risk of asthma through influence 
on T cells, diminished maturation and functioning of 
bronchial smooth muscle cells (airway remodelling early 
in life), lung function and impaired clearance of respira-
tory pathogens [16,27]. Possibly 1a,25(OH)2D modu-
lates T regulatory cells that increase release of IL-10 and 
TGF-b which lowers Th2 cytokine production [26]. 
There has been some criticism concerning the poten-
tial protective effect of vitamin D against asthma and 
its complications. According to Paul et al., currently 
there is no sufficient evidence of a causal relationship 
between vitamin D status and asthma, although it 
seems that vitamin D may have a protective effect 
against asthma exacerbation as it enhances steroid 
responsiveness [26]. 
Finally, vitamin D may influence asthma by regulat-
ing the expression of disease susceptibility genes. Of 
several genes connected to both obesity and asthma, 
currently five are of interest [16]. The gene ADRB2 on 
chromosome 5q codes for the adrenergic b2 receptor 
and influences on sympathetic nervous system as well 
as regulation of airway tone and resting metabolic 
rate. Polymorphism of this gene has been linked to 
different asthma phenotypes, severity and response 
to treatment. Other genes related to obesity-asthma 
phenotypes include NR3C1, which codes for the 
glucocorticoid receptor, TNF-a and the lymphotoxin–A 
genes with a possible role in mediation of allergic 
responses, several variants of vitamin D receptor 
(VDR) gene and protein kinase C-a (PRKCA). The 
association of SNPs within the protein kinase Ca gene 
with BMI was found by Murphy et al. [28]. This enzyme 
not only plays a role in cellular proliferation and dif-
ferentiation, cell cycle regulation, adhesion, survival 
and apoptosis, but also inhibits pre-adipocyte differ-
entiation and insulin signalling which are important 
determinants of human obesity. Polymorphism of the 
PRKCA gene contributes to increased adipose tissue 
accumulation as well as to asthma pathogenesis by 
different mechanisms including airway inflammation, 
mucus production, airway remodelling and leukot-
riene signalling [28].
In summary, the nature of the asthma-obesity 
relationship is very complex and involves several 
mechanisms, of which major roles are played by 
bronchial smooth muscle cells dysfunction, inflam-
matory mediators and oxidative stress, dietary and 
genetic factors. 
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